Dr Tomonori Mizutani speaks to ecancer at the SIOG 2019 meeting in Geneva about JCOG, the Japan Clinical Oncology Group.

The Japan Clinical Oncology Group (JCOG)'s mission is to establish and advance standard treatments for various types of cancers.

They conduct a variety of multi-center, multi-disciplinary phase II or phase III trials that combine various modalities such as drugs, surgery, radiotherapy, and endoscopy.

Dr Mizutani explains how JCOG will be changing the scene of geriatric oncology in Japan, and how putting the geriatric assessment to use in Japan will streamline this process.

Dr Mizutani wants to put an end to and age-based discrimination in the Japanese healthcare system.

This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.